Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 62  Show
  1. 1
    "A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma."
    van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., van den Eynde B., Knuth A., Boon T.
    Science 254:1643-1647(1991) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Tissue: Skin.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 4 other entries.

  3. 3
    "The genetic polymorphism of melanoma-associated antigen 1 in Chinese normal donors and hepatoma patients."
    Wang L.P., Chen H.S., Mei M.H., Qin L.L., Cong X., Fei R., Xu J., Wei L.
    Zhonghua Gan Zang Bing Za Zhi 12:151-155(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT ALA-32.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
    Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A.
    Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ALA-32.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  5. 5
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Testis.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12927 other entries.

  6. 6
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12 and mapped to 21 other entries.

  7. 7
    "The DNA sequence of the human X chromosome."
    Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.
    Bentley D.R.
    Nature 434:325-337(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2134 other entries.

  8. 8
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ALA-32.
    Category: Sequences.
    Tissue: Skin.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50448 other entries.

  10. 10
    "Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes."
    Gaugler B., van den Eynde B., van der Bruggen P., Romero P., Gaforio J.J., De Plaen E., Lethe B.G., Brasseur F., Boon T.
    J. Exp. Med. 179:921-930(1994) [PubMed] [Europe PMC] [Abstract]
    Cited for: MUTAGENESIS.
    Category: Pathology & Biotech.
    Tissue: Blood.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  11. 11
    Cited for: SUBCELLULAR LOCATION.
    Category: Subcellular Location.
    Source: UniProtKB/Swiss-Prot (reviewed).
  12. 12
    "MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription."
    Laduron S., Deplus R., Zhou S., Kholmanskikh O., Godelaine D., De Smet C., Hayward S.D., Fuks F., Boon T., De Plaen E.
    Nucleic Acids Res. 32:4340-4350(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SNW1 AND HDCA1.
    Category: Function, Subcellular Location, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 2 other entries.

  13. 13
    "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
    Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.
    Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 7304 and mapped to 5 other entries.

  14. 14
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 18117 other entries.

  15. 15
    "A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3."
    Hulsmeyer M., Chames P., Hillig R.C., Stanfield R.L., Held G., Coulie P.G., Alings C., Wille G., Saenger W., Uchanska-Ziegler B., Hoogenboom H.R., Ziegler A.
    J. Biol. Chem. 280:2972-2980(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 161-169 IN COMPLEX WITH HLA CLASS I HISTOCOMPATIBILITY COMPLEX.
    Category: Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 1 other entry.

  16. 16
    "Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity."
    Kumar P., Vahedi-Faridi A., Saenger W., Ziegler A., Uchanska-Ziegler B.
    Protein Sci. 18:37-49(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 161-169 IN COMPLEX WITH HLA CLASS I HISTOCOMPATIBILITY COMPLEX.
    Category: Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  17. 17
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 974 and mapped to 2 other entries.

  18. 18
    "Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library."
    Chames P., Hufton S.E., Coulie P.G., Uchanska-Ziegler B., Hoogenboom H.R.
    Proc. Natl. Acad. Sci. U.S.A. 97:7969-7974(2000) [PubMed] [Europe PMC] [Abstract]
    Category: Structure.
    Source: PDB:1W72.

    This publication is mapped to 2 other entries.

  19. 19
    "TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity."
    Chames P., Willemsen R.A., Rojas G., Dieckmann D., Rem L., Schuler G., Bolhuis R.L., Hoogenboom H.R.
    J. Immunol. 169:1110-1118(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Structure.
    Source: PDB:1W72.

    This publication is mapped to 2 other entries.

  20. 20
    "The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies."
    Suyama T., Ohashi H., Nagai H., Hatano S., Asano H., Murate T., Saito H., Kinoshita T.
    Leuk. Res. 26:1113-1118(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Annotation: The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies.
    Source: GeneRIF:4100.

    This publication is mapped to 2 other entries.

  21. 21
    "Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma."
    Zerbini A., Pilli M., Soliani P., Ziegler S., Pelosi G., Orlandini A., Cavallo C., Uggeri J., Scandroglio R., Crafa P., Spagnoli G.C., Ferrari C., Missale G.
    J. Hepatol. 40:102-109(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: Spontaneous in vivo priming of MAGE-specific T cell response and high frequency of MAGE1 and MAGE3 expression in hepatocellular carcinoma makes this antigen potential candidate for MAGE-specific immunotherapy in hepatocellular carcinoma.
    Source: GeneRIF:4100.

    This publication is mapped to 6 other entries.

  22. 22
    "A novel protein-DNA interaction involved with the CpG dinucleotide at -30 upstream is linked to the DNA methylation mediated transcription silencing of the MAGE-A1 gene."
    Zhang J., Yu J., Gu J., Gao B.M., Zhao Y.J., Wang P., Zhang H.Y., De Zhu J.
    Cell Res. 14:283-294(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: a novel sequence-specific DNA-protein interaction at the -30 CpG dinucleotide upstream of the gene was found having a vital part to play in the DNA methylation mediated transcription silencing of the MAGE-A1 gene.
    Source: GeneRIF:4100.

    This publication is mapped to 2 other entries.

  23. 23
    "Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue."
    Hudolin T., Juretic A., Spagnoli G.C., Pasini J., Bandic D., Heberer M., Kosicek M., Cacic M.
    Prostate 66:13-18(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Expression, Sequences.
    Annotation: Present by immunocytochemistry in normal prostate prostatic hypertrophy and prostate cancer.
    Source: GeneRIF:4100.

    This publication is mapped to 13 other entries.

  24. 24
    Category: Interaction.
    Source: IntAct:P43355.

    This publication is mapped to 1504 other entries.

  25. 25
    "Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells."
    Loriot A., De Plaen E., Boon T., De Smet C.
    J. Biol. Chem. 281:10118-10126(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells.
    Source: GeneRIF:4100.

    This publication is mapped to 7 other entries.

1 to 25 of 62  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again